These results indicate that the combination of the metabolite classifier and AFP further improves the diagnostic accuracy for T2DM(+) HCC and has critical clinical significance in the surveillance and early detection of HCC in T2DM individuals. The gene discussed is AFP; the disease is type 2 diabetes mellitus.